HSU-70848-17452
4 vaccinations
3 coded responses
51 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 957 / CA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Moderna
-
2021-01-09
Registered in v-safe
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
-
2021-02-05
Dose 2 — Moderna
- 2021-02-05
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-08
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-21
- 2021-02-26
- 2021-03-05
- 2021-03-12
-
2021-03-19
Survey response — day 42, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
- 2021-08-06
-
2021-10-27
Dose 3 — ModernaCo-administered: Flu
- 2021-10-27
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Night sweats — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Night sweatsMedDRA releases: 2024-11 · check-in free text available
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-03
- 2021-12-08
- 2022-01-28
- 2022-04-27
-
2022-10-21
Dose 4 — Pfizer-BioNTech
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 21, dose 4MedDRA: Cholestasis of pregnancy, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnancy cholestasis and pre-eclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — day 21, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-14
Call successfulNot applicable - Accidental Reporting
- 2022-11-18
- 2022-11-27
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-10-27 | Moderna | Flu |
| 4 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — day 42, dose 2
Symptoms: Headaches
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Night sweats
Release 12 — day 21, dose 4
Symptoms: Pregnancy cholestasis and pre-eclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholestasis of pregnancy | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Night sweats | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release